KYNTRA BIO, INC. Current Assets
KYNTRA BIO, INC. (KYNB) had Current Assets of $96.83 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $96.83M.
- 2026-03-31: Assets, Current $101.36M.
- 2025-12-31: Assets, Current $99.07M.
- 2025-09-30: Assets, Current $133.42M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $96.83M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $101.36M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $99.07M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $133.42M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $162.32M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $148.53M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $196.51M 10-K · filed 2026-03-16 |
| 2024-09-30 | $244.53M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $209.46M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $278.17M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $331.56M 10-K · filed 2025-03-17 |
| 2023-09-30 | $364.11M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $411.36M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $430.55M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $492.83M 10-K · filed 2024-02-26 |
| 2022-09-30 | $474.22M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $520.64M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $524.41M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $474.06M 10-K · filed 2023-02-27 |
| 2021-09-30 | $573.40M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $564.47M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $621.69M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $755.11M 10-K/A · filed 2022-03-04 |
| 2020-09-30 | $737.48M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $727.17M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $736.40M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $702.49M 10-K · filed 2021-03-01 |
| 2019-09-30 | $786.48M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $805.79M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $579.00M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $690.01M 10-K · filed 2020-03-02 |
| 2018-09-30 | $678.78M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $720.08M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $717.16M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $748.97M 10-K · filed 2019-02-27 |
| 2017-09-30 | $741.46M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $371.34M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $256.58M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $266.52M 10-K · filed 2018-02-27 |
| 2016-09-30 | $253.46M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $252.31M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $184.00M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $200.56M 10-K · filed 2017-03-01 |
| 2015-09-30 | $232.57M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $263.58M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $155.40M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $198.24M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |